Bahadir Aslancan

Bahadir Aslancan

Auto-generated profile, based on publicly available information

Bahadir Aslancan

Department of Dermatology and Venereology, Şanlıurfa Training and Research Hospital , Şanlıurfa

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2026 in Skin Health and Disease
Verified
Journal Article
Open access
ÖKömer Karakoyun
ömer Karakoyun
KKKadir Kaya
Kadir Kaya
ZAZeynel Abidin Akar
Zeynel Abidin Akar
NENur Ecer
Nur Ecer
BABahadır Aslancan
Bahadır Aslancan
EAErhan Ayhan
Erhan Ayhan
Background: Psoriasis is a systemic inflammatory disease associated with sleep disturbance and musculoskeletal involvement. Data on temporomandibular joint (TMJ) function in psoriasis and its relationship with sleep quality, psoriatic arthritis (PsA) and systemic treatment are limited. We hypothesized that temporomandibular functional limitation would be associated primarily with PsA rather than with psoriasis itself, whereas sleep quality would relate mainly to cutaneous disease activity and treatment status. Objectives: To compare TMJ function and sleep quality between patients with psoriasis and healthy control participants, and to test whether these parameters differ according to PsA status and systemic treatment. Methods: This prospective controlled cross-sectional study included 105 patients with psoriasis and 73 age- and sex-matched healthy control participants. Patients were grouped as receiving no systemic therapy; receiving nonbiologic systemic therapy (methotrexate, acitretin or ciclosporin; no patient received an oral small-molecule agent such as apremilast or a tyrosine kinase 2 inhibitor); or receiving interleukin (IL)-17-/IL-23-targeted biologic therapy. No patient was receiving an anti-tumour necrosis factor (TNF) agent. Disease severity was assessed using Psoriasis Area and Severity Index (PASI), TMJ functional limitation using the 20-item Jaw Functional Limitation Scale (JFLS-20) and sleep quality using the Pittsburgh Sleep Quality Index (PSQI). Results: Global JFLS-20 scores did not differ significantly across healthy control participants and psoriasis treatment subgroups (P = 0.81). However, patients with PsA had higher mean (SD) JFLS-20 scores than those without PsA [0.80 (0.27) vs. 0.45 (0.22); P < 0.001]. PSQI scores were higher in patients who were not receiving systemic therapy or who were on nonbiologic systemic therapy, whereas patients treated with biologics, who also had markedly lower PASI scores, had scores comparable to healthy control participants. Poor sleep quality occurred in 60% (n = 25/42) and 60% (n = 12/20) of the no systemic treatment and nonbiologic systemic treatment groups compared with 10% (n = 7/73) of healthy control participants and 7% (n = 3/43) of patients treated with biologics. PASI correlated with PSQI (r = 0.49; P < 0.001), while PsA status independently predicted JFLS-20. Conclusions: Sleep impairment in patients with psoriasis was associated mainly with cutaneous disease activity and treatment status, whereas functional limitation of the TMJ was associated primarily with PsA rather than with psoriasis itself. As patients treated with biologics also had substantially lower disease activity, the better sleep quality in this group cannot be attributed to biologic therapy itself and may reflect lower disease burden and responder-related factors. As no patients on anti-TNF agents were included, these observations apply to IL-17- and IL-23-targeted agents rather than to biologics as a whole.

14 September 2026 in Selcuk Tip Dergisi
Verified
Journal Article
Closed access
BABahadir Aslancan
Bahadir Aslancan
CBCagdas Boyvadoglu
Cagdas Boyvadoglu
OSOmer Faruk Solak
Omer Faruk Solak
NKNecmettin Kirtak
Necmettin Kirtak
ÖKömer Karakoyun
ömer Karakoyun
Amaç: Gastroenterolojik hastalık nedeniyle yatırılan ve dermatoloji konsültasyonu gerektiren erişkin hastalarda saptanan kutanöz bulguların dağılımını ve klinik özelliklerini değerlendirmek. Gereç ve Yöntemler: Bu tek merkezli, prospektif, kesitsel tanımlayıcı çalışmada, Eylül 2022 ile Eylül 2023 arasında Gaziantep Üniversitesi Tıp Fakültesi Gastroenteroloji Servisi’nde yatan ve dermatolojik bulgusu bulunan erişkin hastalar değerlendirildi. Demografik veriler, mevcut gastroenterolojik tanı, kullanılan ilaçlar, deri semptomları, lezyonların yerleşimi, morfolojisi, süresi ve dermatolojik tanıları kaydedildi. Tanılar öykü ve dermatolojik muayene temelinde konuldu; gerekli olgularda KOH ile direkt mikroskobik inceleme, yara kültürü ve histopatolojik inceleme kullanıldı. Veriler tanımlayıcı olarak sunuldu. Bulgular: Çalışmaya 207 hasta dahil edildi (107 erkek [%51,69] ve 100 kadın [%48,31]; ortalama yaş 54,30 ± 18,75 yıl). En sık altta yatan tanılar pankreas hastalıkları (%26,09), hepatobiliyer hastalıklar (%23,67), karaciğer sirozu (%19,81), gastrointestinal malignite (%16,43) ve inflamatuvar bağırsak hastalığı (%8,21) idi. En sık kutanöz bulgular kaşıntı (%60,38), başlıca ikter veya solukluk şeklinde renk değişikliği (%56,52), kserozis kutis (%45,41), hiperkeratotik değişiklikler (%43,47) ve enfeksiyonlar (%35,26) olarak saptandı. Sonuç: Gastroenteroloji servisinde yatan hastalarda dermatolojik bulgular geniş bir klinik yelpaze göstermektedir. Bu konsültasyon temelli seçilmiş kohortta kaşıntı, renk değişikliği ve kserozis öne çıkmıştır. Bulgular, gastroenteroloji servislerinde kutanöz semptomu olan hastalarda dermatolojik değerlendirmenin önemini desteklemekle birlikte, tüm gastroenteroloji hastaları için prevalans verisi olarak yorumlanmamalıdır.